Cargando…
Induction of circulating phospholipase A(2) by intravenous administration of recombinant human tumour necrosis factor
We have examined the effects of intravenous infusion of recombinant human tumour necrosis factor (rh-TNF) on serum activity of phospholipase A(2) (PLA(2)) in patients with malignancies. Nine patients received a 24 h continuous intravenous infusion ranging from 1.0 × 10(5) U/m(2) to 3.0 × 10(5) U/m(2...
Autores principales: | Pruzanski, Waldemar, Sherman, Matthew L., Kufe, Donald W., Vadas, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365345/ https://www.ncbi.nlm.nih.gov/pubmed/18475466 http://dx.doi.org/10.1155/S0962935192000358 |
Ejemplares similares
-
Extracellular phospholipase A(2): causative agent in circulatory collapse of septic shock?
por: Vadas, P., et al.
Publicado: (1988) -
Inhibition of the activity of pro-inflammatory secretory phospholipase A(2) by acute phase proteins
por: Pruzanski, W., et al.
Publicado: (1996) -
Preface
por: Vadas, Peter, et al.
Publicado: (1994) -
Tenidap sodium inhibits secretory non-pancreatic phospholipase A(2) synthesis by foetal rat calvarial osteoblasts
por: Pruzanski, W., et al.
Publicado: (1995) -
Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor.
por: Mahony, S. M., et al.
Publicado: (1988)